Sept. 26 2019 iOmx Therapeutics Announces Discovery of Novel, Druggable Immune-Checkpoint Targets
Sept. 24 2019 Salarius Pharmaceuticals Achieves Dose-Escalation Milestones in Ongoing Phase 1/2 Ewing Sarcoma and Phase 1 Advanced Solid Tumor Clinical Trials
Sept. 23 2019 Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek™ Prostate Cancer Study
Oct. 13-15 2019 American Neurological Association Annual Meeting
Oct. 22-23 2019 BIO Investor Forum
Oct. 25-30 2019 ACG World Congress
Nov. 6-10 SITC 2019
Hospital antibiotic developer Aridis files for $34.5M IPO
